Tao Tan - Personalised Oncology division

Tao Tan - Personalised Oncology division

Davis Auditorium
Start Time: 
Wed, 30/11/2022 - 1:00pm
End Time: 
Wed, 30/11/2022 - 2:00pm

WEHI Wednesday Seminar hosted by Associate Professor Oliver Sieber

Tao Tan

PhD Student - Sieber Laboratory, Personalised Oncology division – Cancer Research & Treatments Theme, WEHI

(this is a PhD Completion seminar)

Moving towards personalised therapeutics for bowel cancer using patient-derived tumour organoids

Davis Auditorium

Online access via Slido
and enter code WEHIWednesday

Including Q&A session

Patient-derived tumour organoids (PDTOs) are emerging as a promising tool for prediction of patient treatment responsiveness and discovery of new treatment opportunities. Nonetheless, multiple challenges still need to be overcome to streamline PDTO assay workflows and translate PDTO drug testing into clinical practise. This seminar will describe development of an imaging-based high-throughput drug screening platform for bowel cancer, its application to prediction of treatment responses for patients with metastatic disease and use as a validation platform for novel drug combination approaches. The bowel cancer PDTO biobank established as a result of this work will provide a resource for future discovery and translational research.

Tao Tan is a final year PhD student. He received his Bachelor’s degree in biology and Master’s degree in pharmacology at Nanjing University in China. He joined WEHI as a PhD student in 2018, undertaking his project in the Sieber laboratory, Personalised Oncology division. He is jointly supervised by Dr Anuratha Sakthianandeswaren.


All welcome!